ANTIBODY-COATED target cells may be killed by suspensions of lymphoid cells after depletion of active phagocytes1–4. Harding et al.5 and Van Boxel et al.6 also report that a non-thymus-derived lymphocyte is responsible for this antibody-dependent cell-mediated cytotoxicity in both the rat and mouse. The further observations that the cytotoxic cell acts through an Fc receptor4 similar to that found on most immunoglobulin (Ig)-bearing cells7,8, and that it can be inhibited by pretreatment with anti-Ig sera6, have led some investigators6 to suggest that this cell is a B lymphocyte. The following experiments, however, describe the cytotoxic effector cell as a non-Ig-bearing lymphoid cell which is not of T cell origin.
Moller, E., Science, 147, 873 (1965).
Holm, G., and Perlmann, P., J. Exp. Med., 125, 721 (1967).
MacLennan, I. C. M., and Loewi, G., Nature, 219, 1069 (1968)
Moller, G., and Svehag, S., Cell. Immunol., 4, 1 (1972).
Harding, H., Pudifin, D. J., Gotch, F., and MacLennan, I. C. M., Nature New Biology, 232, 80 (1971).
Van Boxel, J. A., Stobo, J. D., Paul, W. E., and Green, I., Science, 175, 194 (1972).
Basten, A., Warner, N. L., and Mandel, T., J. Exp. Med., 135, 627 (1972).
Dukor, P., Bianco, C., and Nussenzweig, V., Proc. US Nat. Acad. Sci., 67, 991 (1970).
Schlossman, S. F., and Hudson, L., J. Immunol., 110, 313 (1973).
Perlmann, P., and Perlmann, H., Cell. Immunol., 1, 300 (1970).
Gyöngyössy, M., and Playfair, J. H. L., Cell. Immunol., (in the press).
MacLennan, I. C. M., Clin. Exp. Immunol., 10, 275 (1972).
LoBuglio, A. F., Cotran, R. S., and Jandl, J. H., Science, 158, 1582 (1967).
Huber, H., and Fudenberg, H. H., Int. Arch. Allergy, 34, 18 (1968).s
About this article
Cite this article
GREENBERG, A., HUDSON, L., SHEN, L. et al. Antibody-dependent Cell-mediated Cytotoxicity due to a “Null” Lymphoid Cell. Nature New Biology 242, 111–113 (1973). https://doi.org/10.1038/newbio242111a0
Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30
Frontiers in Immunology (2019)
Molecular Therapy - Methods & Clinical Development (2019)
Advanced Materials (2018)